First Trust Advisors LP Vertex Pharmaceuticals Inc Transaction History

First Trust Advisors LP

$95.8 Billion
Q1 2024

A detailed history of First Trust Advisors LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Trust Advisors LP holds 231,197 shares of VRTX stock, worth $105 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

231,197

Previous 734,835 68.54%

Holding current value

$105 Million

Previous $299 Million 67.68%

% of portfolio

0.1%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $205 Million - $225 Million	-503,638 Reduced 68.54%	231,197 $96.6 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $21.8 Million - $26.1 Million	-63,531 Reduced 7.96%	734,835 $299 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $172 Million - $184 Million	508,389 Added 175.32%	798,366 $278 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $13.5 Million - $15.1 Million	-42,809 Reduced 12.86%	289,977 $102 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $4.87 Million - $5.55 Million	-17,185 Reduced 4.91%	332,786 $105 Million

Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $3.12 Million - $3.51 Million	-10,921 Reduced 3.03%	349,971 $101 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $183 Million - $204 Million	-668,540 Reduced 64.94%	360,892 $104 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $138 Million - $172 Million	588,620 Added 133.53%	1,029,432 $290 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $17.8 Million - $21 Million	-80,615 Reduced 15.46%	440,812 $115 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $5.44 Million - $6.87 Million	30,756 Added 6.27%	521,427 $115 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $16.6 Million - $18.5 Million	91,357 Added 22.88%	490,671 $89 Million
Q2 2021 Oct 12, 2021	SELL	$187.49 - $221.1 $131,617 - $155,212	-702 Reduced 0.18%	399,314 $80.5 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $2.33 Million - $2.75 Million	12,436 Added 3.21%	400,016 $80.7 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $3.4 Million - $3.97 Million	-16,439 Reduced 4.07%	387,580 $83.3 Million
Q4 2020 Feb 02, 2021	SELL	$207.01 - $276.09 $88.1 Million - $118 Million	-425,744 Reduced 51.31%	404,019 $95.5 Million
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $4.53 Million - $5.37 Million	17,708 Added 2.18%	829,763 $226 Million
Q2 2020 Jul 22, 2020	BUY	$225.48 - $295.8 $71.4 Million - $93.7 Million	316,633 Added 63.91%	812,055 $236 Million
Q1 2020 May 06, 2020	BUY	$199.77 - $247.81 $27.7 Million - $34.3 Million	138,446 Added 38.78%	495,422 $118 Million
Q4 2019 Feb 03, 2020	SELL	$166.71 - $223.91 $14.9 Million - $20 Million	-89,458 Reduced 20.04%	356,976 $78.2 Million
Q3 2019 Nov 04, 2019	SELL	$166.23 - $187.09 $36.9 Million - $41.5 Million	-221,798 Reduced 33.19%	446,434 $75.6 Million
Q2 2019 Jul 30, 2019	SELL	$164.61 - $190.37 $11.4 Million - $13.2 Million	-69,332 Reduced 9.4%	668,232 $123 Million
Q1 2019 May 09, 2019	BUY	$163.73 - $194.7 $4.76 Million - $5.66 Million	29,086 Added 4.11%	737,564 $136 Million
Q4 2018 Feb 07, 2019	SELL	$151.91 - $192.21 $1.52 Million - $1.92 Million	-9,977 Reduced 1.39%	708,478 $117 Million
Q3 2018 Oct 25, 2018	BUY	$167.73 - $192.74 $34.3 Million - $39.5 Million	204,780 Added 39.87%	718,455 $138 Million
Q2 2018 Aug 02, 2018	BUY	$145.72 - $169.96 $5.35 Million - $6.24 Million	36,704 Added 7.7%	513,675 $87.3 Million
Q1 2018 Apr 23, 2018	SELL	$151.6 - $177.13 $9.92 Million - $11.6 Million	-65,461 Reduced 12.07%	476,971 $77.7 Million
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $1.73 Million - $1.96 Million	-12,589 Reduced 2.27%	542,432 $81.3 Million
Q3 2017 Oct 24, 2017	BUY	$148.13 - $162.24 $82.2 Million - $90 Million	555,021	555,021 $84.4 Million

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Vertex Pharmaceuticals Inc Transaction History